Clinical proteomics has yielded some early positive results—the identification of potential
disease biomarkers—indicating the promise for this analytical approach to improve the current …

Owing to its availability, ease of collection, and correlation with pathophysiology of diseases,
urine is an attractive source for clinical proteomics. However, many proteomic studies have …

The search for biomarkers in biological fluids that can be used for disease diagnosis and
prognosis using mass spectrometry has emerged to become a state-of-the-art methodology for …

Because of its availability, ease of collection, and correlation with physiology and pathology,
urine is an attractive source for clinical proteomics/peptidomics. However, the lack of …

A scheme for generating Schrödinger-cat-like states of a single-mode optical field by means
of conditional measurement is proposed. Feeding a squeezed vacuum into a beam splitter …

Urinary biomarkers for diabetes, diabetic nephropathy, and nondiabetic proteinuric renal
diseases were sought. For 305 individuals, biomarkers were defined and validated in blinded …

Progressive CKD is generally detected at a late stage by a sustained decline in eGFR and/or
the presence of significant albuminuria. With the aim of early and improved risk stratification …

Background Diagnosis and curative treatment of cholangiocarcinoma (CC) often comes too
late due to the lack of reliable tumour markers especially in patients with primary sclerosing …

National Kidney Foundation CKD staging has allowed uniformity in studies on CKD.
However, early diagnosis and predicting progression to end stage renal disease are yet to be …

Background The objective of this study was to assess neurofilament light chain as a Parkinson's
disease biomarker. Methods We quantified neurofilament light chain in 2 independent …